View in EDS HTML Full Text PDF Full Text

Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study.

Saved in:
Bibliographic Details
Title: Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study.
Authors: Durán-Méndez, Alejandro1,2 (AUTHOR), Aguilar-Arroyo, Alma Delia1,3 (AUTHOR), Vivanco-Gómez, Emiliano1,2 (AUTHOR), Nieto-Ortega, Eduardo1,2 (AUTHOR), Pérez-Ortega, Daniela1,2 (AUTHOR), Jiménez-Pérez, Cristian1,3 (AUTHOR), Hernández-Skewes, Karla Y.1,2 (AUTHOR), Montiel-Bravo, Guillermo1,2 (AUTHOR), Roque-Reyes, Oscar J.1,2 (AUTHOR), Romero-Lechuga, Fernanda1,2 (AUTHOR), Medina-Santos, Diana1,4 (AUTHOR), Oriana-Román, Perla1,2 (AUTHOR), Flores-Hernández, Jorge Rafael1,5 (AUTHOR), Méndez-Coca, Juan Daniel1,5 (AUTHOR), Montaño-Olmos, Daniela1,6 (AUTHOR), Farfán-Lazos, Karla Cecilia1,2 (AUTHOR), Tobón-Cubillos, Miranda1,5 (AUTHOR), Viveros-Hernández, América1,2 (AUTHOR), Sevilla-Castillo, Fernando1,2 (AUTHOR), Hernández-Romero, Ángel Raúl1,3 (AUTHOR)
Source: Scientific Reports. 10/5/2021, Vol. 11 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-021-99291-z